CN106866483A - 布瓦西坦的晶型c及其制备方法 - Google Patents
布瓦西坦的晶型c及其制备方法 Download PDFInfo
- Publication number
- CN106866483A CN106866483A CN201710064673.7A CN201710064673A CN106866483A CN 106866483 A CN106866483 A CN 106866483A CN 201710064673 A CN201710064673 A CN 201710064673A CN 106866483 A CN106866483 A CN 106866483A
- Authority
- CN
- China
- Prior art keywords
- crystal formation
- waxitan
- preparation
- solvent
- ray powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
2theta | d间隔 | 相对强度% |
8.90 | 9.93 | 100.00 |
15.03 | 5.89 | 6.31 |
15.74 | 5.62 | 4.46 |
17.35 | 5.10 | 4.06 |
17.85 | 4.96 | 4.33 |
19.17 | 4.62 | 15.55 |
21.61 | 4.11 | 12.67 |
24.98 | 3.56 | 5.03 |
26.90 | 3.31 | 4.37 |
Claims (10)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710064673.7A CN106866483A (zh) | 2017-02-05 | 2017-02-05 | 布瓦西坦的晶型c及其制备方法 |
PCT/CN2018/075177 WO2018141276A1 (zh) | 2017-02-05 | 2018-02-03 | 布瓦西坦中间体的晶型a及其制备方法和布瓦西坦的晶型c及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710064673.7A CN106866483A (zh) | 2017-02-05 | 2017-02-05 | 布瓦西坦的晶型c及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106866483A true CN106866483A (zh) | 2017-06-20 |
Family
ID=59165694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710064673.7A Pending CN106866483A (zh) | 2017-02-05 | 2017-02-05 | 布瓦西坦的晶型c及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106866483A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018141276A1 (zh) * | 2017-02-05 | 2018-08-09 | 苏州鹏旭医药科技有限公司 | 布瓦西坦中间体的晶型a及其制备方法和布瓦西坦的晶型c及其制备方法 |
EP3566760A1 (en) * | 2018-05-07 | 2019-11-13 | Universite Libre De Bruxelles | Method for nucleating crystals from a solution in a capillary tube |
CN110606817A (zh) * | 2018-06-14 | 2019-12-24 | 广东东阳光药业有限公司 | 一种布瓦西坦的精制方法 |
CN111943880A (zh) * | 2019-05-14 | 2020-11-17 | 浙江京新药业股份有限公司 | 一种布瓦西坦晶体及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1303066C (zh) * | 2000-02-23 | 2007-03-07 | Ucb公司 | 2-氧代-1-吡咯烷衍生物、其制备方法和用途 |
CN101506157A (zh) * | 2006-06-08 | 2009-08-12 | Ucb医药有限公司 | 吡咯烷酮共结晶 |
CN105646319A (zh) * | 2015-12-30 | 2016-06-08 | 佛山市隆信医药科技有限公司 | 一种布瓦西坦的制备方法 |
-
2017
- 2017-02-05 CN CN201710064673.7A patent/CN106866483A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1303066C (zh) * | 2000-02-23 | 2007-03-07 | Ucb公司 | 2-氧代-1-吡咯烷衍生物、其制备方法和用途 |
CN101506157A (zh) * | 2006-06-08 | 2009-08-12 | Ucb医药有限公司 | 吡咯烷酮共结晶 |
CN105646319A (zh) * | 2015-12-30 | 2016-06-08 | 佛山市隆信医药科技有限公司 | 一种布瓦西坦的制备方法 |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018141276A1 (zh) * | 2017-02-05 | 2018-08-09 | 苏州鹏旭医药科技有限公司 | 布瓦西坦中间体的晶型a及其制备方法和布瓦西坦的晶型c及其制备方法 |
EP3566760A1 (en) * | 2018-05-07 | 2019-11-13 | Universite Libre De Bruxelles | Method for nucleating crystals from a solution in a capillary tube |
WO2019215022A1 (en) * | 2018-05-07 | 2019-11-14 | Universite Libre De Bruxelles | Method for improving nucleation of crystals from solution |
JP2021522063A (ja) * | 2018-05-07 | 2021-08-30 | ユニヴェルシテ・リブレ・ドゥ・ブリュッセル | 溶液からの結晶の核形成を改善する方法 |
CN110606817A (zh) * | 2018-06-14 | 2019-12-24 | 广东东阳光药业有限公司 | 一种布瓦西坦的精制方法 |
CN110606817B (zh) * | 2018-06-14 | 2023-01-24 | 广东东阳光药业有限公司 | 一种布瓦西坦的精制方法 |
CN111943880A (zh) * | 2019-05-14 | 2020-11-17 | 浙江京新药业股份有限公司 | 一种布瓦西坦晶体及其制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106866483A (zh) | 布瓦西坦的晶型c及其制备方法 | |
EP2431039B1 (en) | Therapeutic uses of compounds having combined sert, 5-HT3 and 5-HT1A activity | |
SK2682002A3 (en) | Sulfonyl carboxamide derivatives, method for their production and their use as medicaments | |
NO333128B1 (no) | Fremgangsmate for fremstilling av ¿ krystallinsk form av perindopril erbumin og fremgangsmate for fremstilling av et medikament inneholdende nevnte forbindelse | |
WO2005085199A1 (en) | Novel polymorphs of etoricoxib | |
RU2057120C1 (ru) | N-алкил-3-фенил-3-(2-замещенный фенокси)пропиламин или его фармацевтически приемлемая кислотно-аддитивная соль, способ его получения, фармацевтическая композиция, обладающая ингибирующей поглощение норминефрина активностью | |
JPH10287651A (ja) | プロパノールアミン誘導体、それらの製法、それらを含有する薬剤およびそれらの使用 | |
JP4043236B2 (ja) | 1−環状アミノ−アルキルシクロヘキサン化合物、その薬学的調合物及びこれを鎮痙薬として使用する方法 | |
EP0285278A2 (en) | The use of tetrahydrobenz[C,D]indole-6-carboxamides for the preparation of a medicament for the treating anxiety | |
EP3398614A1 (en) | Agent for preventing and/or treating alzheimer's disease | |
JP2022513030A (ja) | ヒストン脱アセチル化酵素6阻害剤を含む薬学的組成物 | |
JP3797764B2 (ja) | 光安定化組成物 | |
CN109081803B (zh) | 极性氨基酸修饰的吲哚乙醇衍生物,其合成,活性和应用 | |
CN107056643A (zh) | 一种化合物的晶型a及其制备纯化方法 | |
JP2873076B2 (ja) | 複素環薬剤化合物及びその調製法と用途 | |
JP6626093B2 (ja) | 中医薬組成物及びその調整方法 | |
CN106265571A (zh) | 一种奥氮平片剂的制备方法 | |
JP2013509357A (ja) | 3−(置換ジヒドロイソインドール−2−イル)−2,6−ピペリジンジオン多結晶体及び薬用組成物 | |
AU2019283825A1 (en) | Crystalline form of 1 ,3-thiazol-5-ylmethyl [(2r,5r)-5-{[(2s)-2-[(methyl{[2-(propan-2-yl)-1 ,3-thiazol-4-yl]methyl}carbamoyl)amino] -4-(morpholin-4-yl)butanoyl 9amino}-1 ,6-diphenylhexan-2-yl]carbamate or cobicistat | |
HRP20020178A2 (en) | Use of bis-sulphonamides for producing medicaments used for preventing or treating hyperlipidaemia | |
EP0068324A2 (en) | Microcapsule preparation for reducing increased intracranial pressure and a process for preparing the same | |
JP2002504134A (ja) | 疼痛を治療するためのドラフラジン類似体の使用 | |
TW524804B (en) | Heterocyclic derivatives | |
WO2005037841A1 (fr) | Concentricolide et ses derives, preparation associee et compositions pharmaceutiques contenant celui-ci et utilisations correspondantes | |
CN114644570A (zh) | 利多卡因中杂质化合物的去除方法及其所得的产物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190823 Address after: 215 200 3 storeys, 7 building 2358 Chang'an Road, Wujiang District, Suzhou City, Jiangsu Province Applicant after: Suzhou PengXu PharmaTech Co., Ltd. Applicant after: Chengda Pharmaceuticals Co., Ltd. Address before: 215 200 3 storeys, 7 building 2358 Chang'an Road, Wujiang District, Suzhou City, Jiangsu Province Applicant before: Suzhou PengXu PharmaTech Co., Ltd. |
|
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170620 |